CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity

Lu-Lu Yu,Qi Xiao,Bing Yu,Qiao-Li Lv,Zhao-Qian Liu,Ji-Ye Yin
DOI: https://doi.org/10.1016/j.canlet.2023.216219
IF: 9.756
2023-05-05
Cancer Letters
Abstract:Tumor immunotherapy is a new therapeutic approach that has been evolving in the last decade and has dramatically changed the treatment options for cancer. Circular RNAs (circRNAs) are non-coding RNAs (ncRNAs) with high stability, tissue-specific and cell-specific expression. There is growing evidence that circRNAs are involved in the regulation of both adaptive and innate immunity. They play important roles in tumor immunotherapy by affecting macrophage, NK and T cell function. The high stability and tissue specificity make them ideal candidate biomarkers for therapeutic effects. CircRNAs also represent one of promising targets or adjuvant for immunotherapy. Investigations in this field progress rapidly and provide essential support for the diagnosis, prognosis and treatment guidance of cancers in the future. In this review, we summarize the role of circRNAs on tumor immunity from the viewpoint of innate and adaptive immunity, and explore the role of circRNAs in tumor immunotherapy.
oncology
What problem does this paper attempt to address?